On December 1, Kazan began testing the second vaccine developed in Russia “EpiVacCorona” from the scientific center of virology and biotechnology “Vector”. In total, 650 people will be able to be vaccinated, of which 150 will receive a placebo.
Vaccination takes place in City Clinical Hospital No. 7, it is preceded by a full examination of patients: tests, antibodies, PCR smear.
Photo: BUSINESS Online
The lists have already been formed: they include doctors, teachers and Rospotrebnadzor employees, that is, people from a larger risk group. But, as the epidemiologist, the head of the epidemiological department of GAUZ “GKB No. 7”, explained to reporters Natalia Shaikhrazieva, people are constantly screened out, and new applicants call the hotline of the polyclinic, and they are also included in the lists. To get there, you need to periodically call the clinic, the doctor explained.
About 40% of applicants are screened out: in front of the correspondent of “BUSINESS Online” (and we were in the clinic for about two hours) no one passed the selection: many were found to have antibodies, some had sick relatives. Since the beginning of testing, 7 people have received the vaccine (or placebo) at City Clinical Hospital No. 7, Shaikhrazieva said.
–
Photo at the announcement: “BUSINESS Online”
–
